Multicenter Phase II Study of Fertility-Sparing Treatment With Medroxyprogesterone Acetate for Endometrial Carcinoma and Atypical Hyperplasia in Young Women

Kimio Ushijima, Hideaki Yahata, Hiroyuki Yoshikawa, +17

Journal of Clinical Oncology

Outcomes of Fertility-Sparing Surgery for Stage I Epithelial Ovarian Cancer: A Proposal for Patient Selection

Toyomi Satoh, Masayuki Hatae, Yoh Watanabe, +17

Journal of Clinical Oncology

High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway

Kosuke Yoshihara, Tatsuhiko Tsunoda, Daichi Shigemizu, +27

Clinical Cancer Research

Gene expression profiling of advanced‐stage serous ovarian cancers distinguishes novel subclasses and implicates <i>ZEB2</i> in tumor progression and prognosis

Kosuke Yoshihara, Atsushi Tajima, Dai Komata, +11

Cancer Science

Cdh1 ExpressionOncologyEarly StageMedicineTumor Progression +13

Gene Expression Profile for Predicting Survival in Advanced-Stage Serous Ovarian Cancer Across Two Independent Datasets

Kosuke Yoshihara, Atsushi Tajima, Tetsuro Yahata, +14

PLoS ONE

Clinical features of ovarian cancer in Japanese women with germ-line mutations of BRCA1.

Hiroshi Aida, Koichi Takakuwa, Hiroshi Nagata, +17

PubMed

Breast OncologyCancer PathologyEndocrine-related CancerMedicineJapanese Women +11

Associations Between Systemic Status, Periodontal Status, Serum Cytokine Levels, and Delivery Outcomes in Pregnant Women with a Diagnosis of Threatened Premature Labor

K Hasegawa, Yasushi Furuichi, Akihiro Shimotsu, +6

Journal of Periodontology

Mutational analysis of BRCA1 and BRCA2 and clinicopathologic analysis of ovarian cancer in 82 ovarian cancer families: two common founder mutations of BRCA1 in Japanese population.

Masayuki Sekine, Hiroshi Nagata, Shoji Tsuji, +15

PubMed

Brca2 GenesBrca2 MutationMutational AnalysisCancer PathologySomatic Variant +10

Predicting time to ovarian carcinoma recurrence using protein markers

Ji-Yeon Yang, Kosuke Yoshihara, Kenichi Tanaka, +10

Journal of Clinical Investigation

Randomized phase II study comparing docetaxel plus cisplatin, docetaxel plus carboplatin, and paclitaxel plus carboplatin in patients with advanced or recurrent endometrial carcinoma: a Japanese Gynecologic Oncology Group study (JGOG2041)

Hiroyuki Nomura, Daisuke Aoki, Fumiaki Takahashi, +7

Annals of Oncology

MedicineGynecologyPhase Ii StudyCancer TreatmentOncology +5